Syndecan-1

Syndecan-1

Syndecan-1 Overview

Molecule Name
Syndecan-1
Synonyms
SDC1,Syndecan-1,CD138,SYND1,SDC
Drug Development Progress
Drugs in Clinical Trials2
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
Syndecan Proteoglycan 1,CD138 Antigen,SYND1,SDC,Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor,Syndecan,CD138,Syndecan-1,SDC1,Syndecan 1
Background
Syndecan-1 (SYND1 or SDC1) is also known as CD antigen CD138, is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The syndecans mediate cell binding, cell signaling, and cytoskeletal organization and syndecan receptors are required for internalization of the HIV-1 tat protein. The syndecan-1 / SDC1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. It is a useful marker for plasma cells, but only if the cells tested are already known to be derived from blood.

Syndecan-1 Product List

Species
  • Human(5)
Tag
  • His Tag(2)
  • Fc Tag(1)
  • Fc Tag & Avi Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(5)
Conjugate
  • Biotin-labeled(2)
  • Unconjugated(2)
  • FITC Labeled(1)
Grade
  • RUO(5)
Low Endotoxin
  • No(5)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
Syndecan-1
Human Syndecan-1 Protein, Fc Tag
Human
HEK293
SDS-PAGE
ELISAFlow

$360.00

100ug
Syndecan-1
HOTAvitag
SY1-H82F3
Biotinylated Human Syndecan-1 Protein, Fc,Avitag™
Human
HEK293
SDS-PAGE
ELISAFlow

$360.00

25ug
Syndecan-1
Human Syndecan-1 Protein, His Tag
Human
HEK293
SDS-PAGE
ELISAFlow

$360.00

100ug
Syndecan-1
HOTAvitag
SY1-H82E2
Biotinylated Human Syndecan-1 Protein, His,Avitag™
Human
HEK293
SDS-PAGE
ELISAFlow

$360.00

25ug
Syndecan-1
FITC-Labeled Human Syndecan-1 Protein, His Tag
Human
HEK293
SDS-PAGE
ELISAFlow

$330.00

25ug
You Have Viewed 1-5 Of 5 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center)Phase 1 ClinicalUnc Lineberger Comprehensive Cancer Center
Immune System Diseases; Multiple Myeloma
Details
QXL-138AMQXL-138AMPhase 1 ClinicalNammi Therapeutics Inc
Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Gastrointestinal Neoplasms; Lung Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours
Details
Customer Reviews